Moreover, targeting CXCR4 or CXCR7 alone is not sufficient for inhibiting CXCL12-mediated pro-metastatic responses suggesting that compensatory pathways induced by these receptors can allow tumor escape. Here, CXCL12 is linked to neoplasm.